News

Valneva today announced that it has completed recruitment for the pivotal Phase 3 trial of its single-shot chikungunya vaccine candidate, VLA1553.

Th…

Read more

After the first assembly of an axolotl genome was published in 2018, the lab of Elly Tanaka teamed up with scientists at the University of Kentucky to…

Read more

Researchers at IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – demonstrate that different viruses can lead to brain…

Read more

Researchers at GMI – Gregor Mendel Institute of Molecular Plant Biology of the Austrian Academy of Sciences – uncover an ingenious mechanism by which…

Read more

Valneva announced positive data for Part A of the Phase 1/2 clinical trial of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001. Based…

Read more

Centrioles are surrounded by a dense meshwork of proteins called the pericentriolar material (PCM), which together form centrosomes, the main…

Read more

The Austrian Science Fund has granted a doc.fund to a group of researchers from the Max Perutz Labs, the Faculty of Physics of the University of…

Read more

Lamins are structural proteins found at the nuclear periphery, where they regulate the mechanical properties of the nucleus and the organization of…

Read more

Researchers at GMI – Gregor Mendel Institute of Molecular Plant Biology of the Austrian Academy of Sciences, the University of North Carolina at…

Read more

Mature egg cells and early embryos do not generate their own RNA molecules – instead, they rely on stored maternal RNAs to synthesise their proteins.…

Read more

Pluripotent stem cells can give rise to all the different types of specialized cells in the adult organism. Scientists led by Martin Leeb have…

Read more

Valneva and Pfizer today announced initiation of study VLA15-221. The VLA15-221 study builds on previous positive Phase 2 studies, incorporates new…

Read more